Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFA14A
Source: 0001193125-25-086311
Chunk: 13

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFA14A
Chunk 13
---
 on March 12, 2025 and under the headings “Proposal 1: Election of Directors,” “Executive Officers,” “Security Ownership of Certain Beneficial Owners and
Management” and “Executive Compensation,” and “Director Compensation” in Zevra’s
for its annual meeting of stockholders held in 2025, which
was filed with the SEC on April 21, 2025. To the extent holdings of our directors and executive officers of Zevra securities reported in such definitive proxy statement change, such changes will be reflected on Statements of Change in Ownership on
Forms 3, 4 or 5 filed with the SEC. These documents are available free of charge at the SEC’s website at . Copies of the documents are also available free of charge by accessing Zevra’s investor relations website
at .

Contacts

For investor inquiries

Nichol Ochsner

+1 (732) 754-2545

For media inquiries

FTI Consulting

Tanner Kaufman / Kyla MacLennan / Mike Gaudreau